A multidisciplinary research team at Aarhus University has provided fundamental new insight into the mechanism of the medical drug dimethyl fumarate, which is the active component of important treatments for multiple sclerosis ...
Nov 1, 2018
0
3
The overproduction of the BCL-2 protein is due to a defect in the ribosome, the protein factory of the cell. This defect is found in 10% of the pediatric patients with T-cell leukaemia.
Jun 26, 2018
0
0
By taking a deep dive into the molecular underpinnings of Diamond-Blackfan anemia, scientists have made a new discovery about what drives the development of mature red blood cells from the earliest form of blood cells, called ...
Mar 19, 2018
0
3
A study published in the scientific journal Structure (Cell Press) describes the anti-cancer effects of a natural alkaloid extracted from Daffodils. Led by Denis Lafontaine, affiliated with the Faculty of Sciences at the ...
Feb 27, 2018
0
4
In a new study published today in The American Journal of Human Genetics, a multinational team of researchers describes, for the first time, the biological basis of a severe neurological disorder in children.
Aug 3, 2017
0
236
Research from the Stowers Institute provides evidence suggesting that cancer cells might streamline their genomes in order to proliferate more easily. The study, conducted in both human and mouse cells, shows that cancer ...
Jun 22, 2017
0
0
Twenty to forty percent of the patients with the type of leukaemia known as multiple myeloma have a defect in the 'protein factory' of the cell: the ribosome. These patients have a poorer prognosis than patients with intact ...
Dec 9, 2016
0
0
USC Stem Cell scientists have set a "mouse TRAP" to capture the early signs of kidney failure, as described by a recent study published in the Journal of Clinical Investigation. Their new transgenic mouse line uses a technique ...
Jul 11, 2014
0
0
With no cure available, Fragile X syndrome is the most common form of inherited intellectual disability. Individuals with the syndrome cannot produce enough of a protein—called the fragile X mental retardation protein (FMRP)—whose ...
Apr 17, 2014
0
0
A drug developed to treat genetic diseases such as Duchenne muscular dystrophy and cystic fibrosis may need a radical rethink. In a new study published on 25 June in the open access journal PLOS Biology, researchers question ...
Jun 25, 2013
0
0
